Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,932 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
British Gynaecological Cancer Society (BGCS) ovarian, tubal and primary peritoneal cancer guidelines: Recommendations for practice update 2024.
Moss E, Taylor A, Andreou A, Ang C, Arora R, Attygalle A, Banerjee S, Bowen R, Buckley L, Burbos N, Coleridge S, Edmondson R, El-Bahrawy M, Fotopoulou C, Frost J, Ganesan R, George A, Hanna L, Kaur B, Manchanda R, Maxwell H, Michael A, Miles T, Newton C, Nicum S, Ratnavelu N, Ryan N, Sundar S, Vroobel K, Walther A, Wong J, Morrison J. Moss E, et al. Among authors: george a. Eur J Obstet Gynecol Reprod Biol. 2024 Sep;300:69-123. doi: 10.1016/j.ejogrb.2024.06.025. Epub 2024 Jun 21. Eur J Obstet Gynecol Reprod Biol. 2024. PMID: 39002401 Free article. No abstract available.
The current status of PARP inhibitors in ovarian cancer.
McLachlan J, George A, Banerjee S. McLachlan J, et al. Among authors: george a. Tumori. 2016 Oct 13;102(5):433-440. doi: 10.5301/tj.5000558. Epub 2016 Sep 24. Tumori. 2016. PMID: 27716873 Review.
Olaparib and somatic BRCA mutations.
George A, Banerjee S, Kaye S. George A, et al. Oncotarget. 2017 Jul 4;8(27):43598-43599. doi: 10.18632/oncotarget.18419. Oncotarget. 2017. PMID: 28611314 Free PMC article. No abstract available.
The role of Cediranib in ovarian cancer.
Orbegoso C, Marquina G, George A, Banerjee S. Orbegoso C, et al. Among authors: george a. Expert Opin Pharmacother. 2017 Oct;18(15):1637-1648. doi: 10.1080/14656566.2017.1383384. Expert Opin Pharmacother. 2017. PMID: 28933580 Review.
British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for germline and tumor testing for BRCA1/2 variants in ovarian cancer in the United Kingdom.
Sundar S, Manchanda R, Gourley C, George A, Wallace A, Balega J, Williams S, Wallis Y, Edmondson R, Nicum S, Frost J, Attygalle A, Fotopoulou C, Bowen R, Bell D, Gajjar K, Ramsay B, Wood NJ, Ghaem-Maghami S, Miles T, Ganesan R. Sundar S, et al. Among authors: george a. Int J Gynecol Cancer. 2021 Feb;31(2):272-278. doi: 10.1136/ijgc-2020-002112. Epub 2021 Jan 19. Int J Gynecol Cancer. 2021. PMID: 33468564 Review.
3,932 results